Clinical Trial Update: Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients [NA]

View source ↗

Summary

A terminated clinical trial evaluated delivering soluble ferric pyrophosphate via the dialysate to maintain iron balance in patients with end-stage renal diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Soluble Ferric Pyrophosphate (soluble ferric pyrophosphate)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: End Stage Renal Disease (ESRD) | NA | Status: TERMINATED | Results posted: 2015-08-31